Association of liver fibrosis and hypophosphatemia in treatment-naive patients with chronic hepatitis B

被引：0
|
作者：
Jiang, Suling [1 ]
Wang, Jian [2 ,3 ]
Zhu, Li [4 ]
Zhang, Zhiyi [5 ]
Zhan, Jie [1 ]
Ding, Weimao [6 ]
Li, Jie [1 ,2 ,3 ]
Zhu, Chuanwu [4 ]
Huang, Rui [1 ,2 ,3 ]
Wu, Chao [1 ,2 ,3 ]
机构：
[1] Nanjing Med Univ, Nanjing Drum Tower Hosp, Clin Coll, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China
[4] Soochow Univ, Affiliated Infect Dis Hosp, Dept Infect Dis, Suzhou, Jiangsu, Peoples R China
[5] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[6] Huaian 4 Peoples Hosp, Dept Hepatol, Huaian, Jiangsu, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-140
引用
收藏
页码：S1078 / S1079
页数：2
相关论文
共 50 条
  • [31] PARTIAL VIROLOGICAL RESPONSE TO ENTECAVIR IN TREATMENT-NAiVE CHRONIC HEPATITIS B
    Kim, Seung Up
    Chon, Young Eun
    Lee, Chun Kyon
    Heo, Jeong
    Kim, Ja Kyung
    Yoon, Ki Tae
    Cho, Mong
    Lee, Kwan Sik
    Kim, Dong Hwan
    Choi, Eun Hee
    Park, Jun Yong
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2010, 52 (04) : 501A - 502A
  • [32] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
  • [33] Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naive chronic hepatitis B patients
    Li, Min-Ran
    Lu, Jian-Hua
    Ye, Li-Hong
    Sun, Xing-Li
    Zheng, Yan-Hua
    Liu, Zhi-Quan
    Zhang, Hai-Cong
    Liu, Yun-Yan
    Lv, Ying
    Huang, Yan
    Dai, Er-Hei
    MEDICINE, 2016, 95 (34)
  • [34] Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea
    Kwon, Jung Hyun
    Song, Myeong Jun
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Kim, Hee Yeon
    Kim, Chang Wook
    Song, Do Seon
    Chang, U. Im
    Yang, Jin Mo
    You, Chan Ran
    Choi, Sang Wook
    Lee, Hae Lim
    Lee, Sung Won
    Han, Nam Ik
    Nam, Soon Woo
    Kim, Sang Gyune
    Kim, Young Seok
    Kim, Seok Hyun
    Lee, Byung Seok
    Lee, Tae Hee
    Cho, Eun-Young
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 2039 - 2048
  • [35] Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients
    Buti, Maria
    Maria Morillas, Rosa
    Prieto, Martin
    Diago, Moises
    Perez, Juan
    Sola, Ricard
    Bonet, Lucia
    Palau, Antonio
    Testillano, Milagros
    Garcia-Samaniego, Javier
    Rodriguez, Manuel
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (05) : 535 - 542
  • [36] Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B
    Keskin, Onur
    Ormeci, Asli C.
    Baran, Bulent
    Kabacam, Gokhan
    Tuzun, Ali
    Karatayli, Ersin
    Akyuz, Filiz
    Karatayli, Senem
    Bozdayi, A. Mithat
    Onel, Derya
    Badur, Selim
    Idilman, Ramazan
    Kaymakoglu, Sabahattin
    Yurdaydin, Cihan
    ANTIVIRAL THERAPY, 2014, 19 (06) : 543 - 550
  • [37] Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naive Chronic Hepatitis B Patients
    Yu, Hyung Min
    Kwon, So Young
    Kim, Jiwan
    Chung, Hyun Ah
    Kwon, Se Woong
    Jeong, Taek Gun
    An, Sang Hee
    Jeong, Gyung Won
    Yun, Seon Ung
    Min, Jae Ki
    Kim, Jeong Han
    Choe, Won Hyeok
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03): : 146 - 151
  • [38] Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis
    Zeuzem, Stefan
    Soriano, Vicente
    Asselah, Tarik
    Gane, Edward J.
    Bronowicki, Jean-Pierre
    Angus, Peter
    Lohse, Ansgar W.
    Stickel, Felix
    Muellhaupt, Beat
    Roberts, Stuart
    Schuchmann, Marcus
    Manns, Michael
    Bourliere, Marc
    Buti, Maria
    Stern, Jerry O.
    Gallivan, John-Paul
    Voss, Florian
    Sabo, John P.
    Boecher, Wulf
    Mensa, Federico J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1282 - 1291
  • [39] CLINICAL FEATURES AND RISK FACTORS FOR CLEVUDINE RESISTANCE IN TREATMENT-NAiVE CHRONIC HEPATITIS B PATIENTS
    Yim, Hyung Joon
    Kim, Jeong Han
    Choi, You-me
    Jung, Young Kul
    Jung, Eun Suk
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yeon, Jong Eun
    Byun, Kwan Soo
    Um, Soon Ho
    Ryu, Ho Sang
    HEPATOLOGY, 2009, 50 (04) : 525A - 525A
  • [40] Long-term outcomes of entecavir monotherapy in patients with treatment-naive chronic hepatitis B
    Kim, Hyung Joon
    Lee, Hyun Woong
    Park, Ji Hoon
    Lee, Kyeong Heon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 248 - 249
12345